Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Lianna J. Marks, Kathleen McCarten, Qinglin Pei, Yue Wu, Kara M. Kelly, Cindy Schwartz, Suzanne Wolden, Debra L. Friedman, Sharon M. Castellino, Burton Appel

Blood (2023) 142 (Supplement 1): 1699.

https://doi.org/10.1182/blood-2023-179465

Published: 2023

Journal Articles

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Blood (2015) 126 (23): 2636.

https://doi.org/10.1182/blood.V126.23.2636.2636

Published: 2015

Journal Articles

Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group

Kara M. Kelly, MD, Peter D. Cole, MD, Lu Chen, PhD, Kenneth B Roberts, MD, David C. Hodgson, MD, Kathleen McCarten, MD, Steve Y Cho, MD, Cindy Schwartz, MD

Blood (2015) 126 (23): 3927.

https://doi.org/10.1182/blood.V126.23.3927.3927

Published: 2015

Journal Articles

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

Anja Mottok, MD, Rebecca Lea Johnston, Fong Chun Chan, MSc, David W Scott, MBChB, PhD, Debra L. Friedman, MD MS, Cindy Schwartz, MD, Kara M. Kelly, MD, Terzah M. Horton, MD PhD, Christian Steidl, MD

Blood (2015) 126 (23): 175.

https://doi.org/10.1182/blood.V126.23.175.175

Published: 2015

Journal Articles

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

Cindy Schwartz, MD, MPH, Lu Chen, PhD, Louis Constine, MD, Suzanne Wolden, Frank G Keller, MD, Kara M Kelly, MD, Debra l Friedman, MD, MS

Blood (2011) 118 (21): 3649.

https://doi.org/10.1182/blood.V118.21.3649.3649

Published: 2011

Journal Articles

Survival in Adolescents and Young Adults with Hodgkin Lymphoma Treated with Response-Based Chemotherapy on P9425 and P9426 Protocols: A Report From the Children's Oncology Group

Karen S. Fernández, MD, Lu Chen, PhD, Cindy Schwartz, MD, MPH, Allen R. Chauvenet, MD, PhD, Pedro A. de Alarcón, MD

Blood (2011) 118 (21): 91.

https://doi.org/10.1182/blood.V118.21.91.91

Published: 2011

Journal Articles

Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01

Lewis B. Silverman, MD, Kristen Stevenson, Lynda M Vrooman, MD, Jeffrey G Supko, PhD, Barbara Asselin, MD, Uma Athale, MD, Luis A. Clavell, MD, Peter Cole, MD, Kara M Kelly, MD, Caroline Laverdiere, MD, Bruno Michon, MD, FRCPC, Marshall A. Schorin, MD, Cindy Schwartz, MD, MPH, Donna Neuberg, ScD, Stephen E. Sallan, MD

Blood (2011) 118 (21): 874.

https://doi.org/10.1182/blood.V118.21.874.874

Published: 2011

Journal Articles

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

Debra l Friedman, MD, MS, Suzanne Wolden, Louis Constine, MD, Lu Chen, PhD, Kathleen M McCarten, MD, T. J Fitzgerald, Pedro De Alarcon, MD, Allen R. Chen, MD, PhD, MHS, Robert Hutchison, MD, Peter Ehrlich, Nathan L. Kobrinsky, MD, FRCP, Meghan Higman, Shirley Hogan, Lorna Roll, Tanya Trippett, Cindy Schwartz, MD

Blood (2010) 116 (21): 766.

https://doi.org/10.1182/blood.V116.21.766.766

Published: 2010

Journal Articles

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

Frank G Keller, MD, James Nachman, MD, Louis Constine, MD, John Thomson, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Cindy Schwartz, MD

Blood (2010) 116 (21): 767.

https://doi.org/10.1182/blood.V116.21.767.767

Published: 2010

Journal Articles

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

Allen Chen, MD, PhD, Allan Hess, PhD, Sharon Gardner, MD, Tanya Trippett, MD, Pedro de Alarcon, MD, Robert Guillerman, MD, Shirley Hogan, PharmD, Joy Mitchell, Alan Gamis, MD, Vicki Massey, MD, Louis S. Constine, MD, Doojduen Villaluna, MS, Richard Sposto, MD, Cindy Schwartz, MD

Blood (2005) 106 (11): 2087.

https://doi.org/10.1182/blood.V106.11.2087.2087

Published: 2005

Journal Articles

AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease.

Tanya Trippett, M.D., Pedro De Alarcon, M.D., Wendy London, Ph.D., Richard Sposto, Ph.D., Allen Chen, M.D., Sharon Gardner, M.D., Cindy Schwartz, M.D.

Blood (2004) 104 (11): 2496.

https://doi.org/10.1182/blood.V104.11.2496.2496

Published: 2004

NARROW

Performance of Positron Emission Tomography at Diagnosis and Response Assessment in Low and Intermediate-Risk Nodular Lymphocyte Predominant Hodgkin Lymphoma

Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treated on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology Group (COG AHOD0031) Comparative Analysis

Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed Very High Risk Hodgkin Lymphoma (Stages IIIB/IVB) (AHOD0831): A Report from the Children's Oncology Group

Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from Childhood and Adolescent Hodgkin Lymphoma Patients

The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma,

Survival in Adolescents and Young Adults with Hodgkin Lymphoma Treated with Response-Based Chemotherapy on P9425 and P9426 Protocols: A Report From the Children's Oncology Group

Randomized Comparison of IV PEG and IM E. Coli Asparaginase in Children and Adolescents with Acute Lymphoblastic Leukemia: Results of the DFCI ALL Consortium Protocol 05-01

AHOD0031: A Phase III Study of Dose-Intensive Therapy for Intermediate Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

Cyclosporine, Interferon-γ , and Interleukin-2 Immunotherapy Is Tolerable and Induces Autoreactivity in Patients with Recurrent/Refractory Hodgkin Disease Undergoing Autologous Stem Cell Transplantation with BEAM: A COG Study.

AHOD00P1, a Pilot Study of Re-Induction Chemotherapy with Ifosfamide, and Vinorelbine (IV) in Children with Refractory/Relapsed Hodgkin Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only